November 7, 2013
NOVATO — Raptor Pharmaceutical Corp (Nasdaq: RPTP) on Thursday reported its third-quarter net loss expanded by nearly 70 percent, attributed to more development dollars poured into its recently approved lead drug.
For the nine months ended in September, Raptor’s net loss was $57.4 million, or $1.01 per share, compared with a net loss of $27.3 million, or $0.56 per share, for the nine-month period ended in August 2012.
September 30, 2013
The San Francisco Bay Regional Water Quality Control Board is is accepting comments on the Renewal of Conditional Waiver of Waste Discharge Requirements for Grazing Operations in the Tomales Bay Watershed. …
Petaluma-based Scott Laboratories announced the release of its first-ever Cider Handbook. …
BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) of San Rafael said it has closed the first patient in the Phase 1/2 trial for BMN 190. …
Ken Frank, executive chef and owner of La Toque restaurant in Napa’s downtown, launched La Toque’s new iPad wine list. …
June 3, 2013
Chicago-based investment adviser Morningstar has increased its fair value estimates for BioMarin Pharmaceutical stock. …
BioCision, a developer of products used to eliminate variability in lab procedures based in Larkspur, recently announced a collaboration with ATCC. …
College of Marin held its annual scholarship awards ceremony, awarding a total of $44,470 to 78 students. …
Marin County’s luxury home market has been churning strongly since the worst of the housing crisis, with the number of sales up 56 percent in April versus the same period in 2012. …
May 9, 2013
SAN RAFAEL — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) recently reported a net loss of $39.8 million, or 31 cents per share, for the first quarter ended March 31, compared to a net loss of $24 million in the same period last year.
February 21, 2013
SAN RAFAEL — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) on Thursday reported its fourth-quarter and 2012 net losses about doubled from a year before.
Rumors have been circulating that BioMarin is an acquisition target, but the company CEO fended off that speculation recently.
January 7, 2013
SAN RAFAEL — BioMarin Pharmaceutical Inc. (NASDAQ: BRMN) today said it has acquired San Diego-based Zacharon Pharmaceuticals, a private biotechnology company focused on developing small molecules targeting pathways of glycan and glycolipid metabolism.
January 7, 2013
More than a dozen North Bay companies undertook major expansions or moves: TricorBraun WinePak, Raydiance, Enphase Energy, General Dynamics, Langers of Sonoma, Anette’s Chocolates Napa Valley, Marmot Mountain, Wineshipping, BioMarin Pharmaceutical, EO Products, Birkenstock USA, Toys for Bob, Adventist Health, Amorim Cork America, SPG Solar, Biosearch Technologies and Telltale Games.
After Hours: Mountain Play fundraiser; BioMarin ribbon-cutting; Star Staffing at the Hispanic Chamber ExpoJanuary 7, 2013
Nov. 3, 2012: Mountain Play Assn. held its annual fall fundraising gala, The Sound of the Mountain, at the JCC in San Rafael / Oct. 18, 2012: Ribbon-cutting for BioMarin Pharmaceutical’s new San Rafael Corporate Center / Oct. 25, 2012: Star Staffing at the Hispanic Chamber of Commerce’s Business Expo
November 5, 2012
SAN RAFAEL — BioMarin Pharmaceuticals (Nasdaq:BMRN) shares jumped by more than 30 percent Monday after the company announced a key study on its GALNS therapy ended, the first step in seeking regulatory approval for its treatment of the rare enzyme deficiency condition.
September 17, 2012
Bank of Marin promoted Mike Kadel to first vice president. …
SWA Group, a landscape architecture, planning and urban design firm, named Chih-Wei Lin as the principle of the firm in Sausalito. …
Sutter Medical Foundation announced the arrival of board-certified family medicine physician Nigel Brandstater, M.D. …
The Burbank Housing board of directors announced it has appointed Charles A. Cornell to succeed John Lowry, when he retires this year in September, as executive director and president. …
BioMarin Pharmaceutical Inc. announced Jeff Ajer, the current vice president of commercial operations, the Americas, will be promoted to senior vice president, chief commercial officer. …
Mandi Nash has joined Grgich Hills Estate as brand associate, a new position for the winery. …
Cuvaison Estate Wines announced the formation of a new in-house sales team responsible for the sales of the Cuvaison and Brandlin Vineyard brands nationwide. …
Jennifer Brown has been appointed director of public relations and communication for Wilson Daniels. …
August 2, 2012
NOVATO — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today reported its net loss expanded five fold in the second quarter and first half of this year, outpacing strong revenue growth.
July 30, 2012
As construction crews prepare 120,000 square feet of offices in San Rafael Corporate Center for the expansion of Novato-based BioMarin Pharmaceutical later this year, Marin Economic Forum has analyzed how much the arrival of more than 300 employees in the city will affect the greater business community. The figures are breathtaking.
Industry West Commerce Center off Todd Road in southwest Santa Rosa has brought in 55,000 square feet of leases in recent months, bringing the 275,000-square-foot industrial developments to 88 percent occupancy.
In another sign of increased economic activity in Petaluma, telecommunications equipment startup Cyan and real estate brokerage Keller Williams expanded by 8,700 square feet all together at Basin Street Properties’ Redwood Business Center office building at 1383 N. McDowell Blvd.
June 18, 2012
In an effort to gauge how the region’s major employers are dealing with continued economic uncertainty, the North Bay Business Journal reached out to major companies with a series of employment-related questions, in addition to identifying the top human resources professional at each organization.
The results, from tech to health care, to hospitality to manufacturing, show that many of the major players are faring better, some even thriving, but challenges nonetheless remain.
March 12, 2012
MARIN COUNTY — Central and northern Marin office space markets have strengthened significantly in the past 12 months, with vacancy rates finally dipping below 20 percent for the county.
March 5, 2012
NOVATO — Mark Wood is vice president of human resources of BioMarin Pharmaceutical, which has approximately 700 employees. He joined the pharmaceutical company in 2004 and oversees all HR functions as well as public relations and corporate communications. Before joining BioMarin, he was a sole proprietor of an HR consulting practice from 2002 to 2004 and previously worked as vice president of human resources and consulting for AG Consulting. He also previously was manager of compensation and quantitative analysis at Genentech and held numerous HR positions with Wells Fargo Bank.
March 5, 2012
NOVATO — Remy Gross is currently the vice president of business development and technology advancement at the Buck Institute for Research on Aging. His duties at the Buck include the increase of deal flow through global corporate collaborations and new company formation.
February 13, 2012
NOVATO — Remy Gross is director of technology transfer for The Buck Institute on Age Research. He will be a featured speaker at the Business Journal’s Impact Marin Conference on MArch 14. Business Journal: The Life sciences and biotech industries seem to be on an upswing in Marin County, with numerous companies expanding in and [...]
January 6, 2012
SAN RAFAEL — Novato-based BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today said it plans to relocate several hundred employees from its Bel Marin Keys headquarters plant to downtown San Rafael by the end of this year.
December 1, 2011
NOVATO — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has received approval from the U.S. Food and Drug Administration for a manufacturing facility expansion in Novato that the drug makers says will support up to $1 billion in revenue for its growing enzyme replacement therapy portfolio.
November 30, 2011
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today said it made an upfront payment of $81 million to complete the buy back of certain intellectual property from SA Pathology, a unit of the Central Adelaide Local Health Network in Australia.The transaction will generate between $10 to $15 million a year in cash, with no incremental operating costs, according to Jean-Jaques Bienaime, chief executive officer of BioMarin.
NBBJ Pulse PollLoading ...
Top North Bay Real Estate Projects
With the simple criteria that they be projects available for occupancy in 2013, nominations were solicited from architects, contractors, commercial real estate and other professionals from around the North Bay.
From their nominations, the 17 winners were selected by the Business Journal editorial staff for recognition. Read details on what made these projects notable. [read profiles of the winning projects]
Most popular recent items
- Walter Robb, Whole Foods Market: Consumers want transparency on food 9,190 view(s) | posted on November 18, 2013
- Who’s Who in Insurance (Life, Disability and Health) 7,727 view(s) | posted on October 12, 2009
- New research suggests wine vs. beer thinking outdated 5,964 view(s) | posted on December 9, 2013
- Winners of first Wine Industry Awards named 5,919 view(s) | posted on November 11, 2013
- Zapolski enters $25M joint venture on downtown Napa shopping center rehab 4,251 view(s) | posted on December 5, 2013
Latest reader comments
Business Journal connections